Propeller Health, formerly Asthmapolis, has received FDA clearance for a platform that includes a new smart inhaler and is geared for patients with either asthma or COPD.
"Our goal is to minimize or eliminate exacerbations – that drives everything we do. Key to that, particularly as we move deeper into COPD, is optimizing both the patient and provider experience on Propeller," David Van Sickle,...
The Inspiromatic inhaler.
Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...
Wellframe, a Boston-based patient engagement and care management technology company, has raised $1.5 million in seed funding from a bevy of high profile investors and entrepreneurs, such as athenahealth CEO Jonathan Bush. Other investors in the round include Tim Draper, founder and managing director of Draper Fisher Jurvetson; Sir Sabaratnam Arulkumaran, president of the British Medical...
"Ten years from now, we'll be talking about behavioral change methods, not the technology."
That was a prediction Don Jones, vice president of global strategy and market development for Qualcomm Life, the healthcare connectivity division of San Diego-based telecommunications firm Qualcomm, made Friday at the University of Southern California's seventh annual Body Computing Conference in Los...
Asthmapolis, the Madison-Wisconsin based smart inhaler company, is changing its name as it moves beyond both asthma treatment and GPS mapping. The company's rebranding as Propeller Health will correspond with a broadening of its offerings to include chronic obstructive pulmonary disease, or COPD, a lung condition similar to asthma except more likely to afflict an older population.
"From a...
Futura mHealth, a Philadelphia-based joint venture from Futura Mobility and HGE Healthcare Solutions, a Temple University spin off company, has developed an app the company says can reduce hospital admissions for chronic obstructive pulmonary disease (COPD) by 38 to 40 percent.
A chronic lung condition, COPD manifests itself as occasional attacks of extreme shortness of breath, called...
Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis, announced that it has raised $5 million in its first round of funding. The investment was led by The Social+Capital Partnership, a relatively new venture fund started by Chamath Palihapitiya, an early executive at Facebook who left to start the investment fund...
UK mobile operator O2, a subsidiary of Telefonica, recently announced two new mobile health programs: Help at Hand, an emergency response system sold directly to consumers, and Health at Home, a telehealth system marketed to providers.
Help at Hand is a monthly subscription service for people who are self-sufficient and mobile, but have a condition where loved ones might worry about them falling...
A WellPoint health plan in Florida, called Amerigroup Florida, announced that it will offer Asthmapolis' FDA-cleared mobile health device and service to its members with asthma.
Asthmapolis' device is a sensor that sits atop (most) inhalers used by patients who have asthma or COPD. The sensor transmits data to a companion app on the user’s mobile phone every time the inhaler is used. The app can...
A screenshot from Exco's clinical trial software.
One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
